cerebrovascular diseasecerebrovascular diseasefabry’s disease) ccsadasil (ad aate opat...

68
Neuropathology lecture series Cerebrovascular Disease Cerebrovascular Disease Kurenai Tanji, M.D., Ph.D. December 11, 2007

Upload: others

Post on 29-Jul-2020

5 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Neuropathology lecture series

Cerebrovascular Disease

gy

Cerebrovascular Disease

Kurenai Tanji, M.D., Ph.D.

December 11, 2007

Page 2: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Physiology of cerebral blood flowy gyBrain makes up only 2% of body weightPercentage of cardiac output: 15-20%g pPercentage of O2 consumption (resting): 15%Distribution of circulation:

♦ anterior circulation > posterior circulation♦ anterior circulation > posterior circulation(70%) (30%)

♦ gray matter > white matter

Page 3: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Bl d fl i f i fBlood flow is a fraction of:♦ perfusion pressure

resistance of asc lar bed as modified b♦ resistance of vascular bed as modified by:♦ arterial pressure♦ pCO2, pH, and oxygen♦ intracranial pressure♦ blood viscosity♦ neurotransmitters???♦ neurotransmitters???

Relatively constant blood flow primarily governed by autoregulatory mechanism

Page 4: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Effects of cerebral perfusion pressure on cerebral blood flow

Cerebral blood flow

autoregulationautoregulation

Low BP Normal High BP

Mendolow AD et al. Br J Surg 1983

Page 5: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

R

Page 6: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

HIP

TRUNKTRUNKARMHAND

FACE

LEG

Page 7: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

••StriatumStriatum: Lenticulostriate arteries

from MCA(mostly) & ACA

••Globus PallidusGlobus Pallidus: Ant. choroidal arteries from ICA

••Thalamus & HippocampusThalamus & Hippocampus: PCA

Page 8: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Boundery zone

(watershed)

most distal part of arterial p

irrigation

Page 9: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 10: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Epidemiology of strokeEpidemiology of stroke

• Almost 750,000 new or recurrent strokes per year in the U Sthe U.S.

• Third leading cause of death in the U.S.; second worldwide

• Almost 4 million Americans are living with gneurologic deficits due to stroke

• Prevention prevention and prevention (Only 1 2% of• Prevention, prevention, and prevention (Only 1-2% of ischemic stroke patients nationally are treated with Tissue Plasminogen Activator.)

Page 11: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

StrokeClassical definitions (WHO 1980):Classical definitions (WHO 1980):“Rapidly developing clinical signs of focal (at times

global) disturbance of cerebral function, lasting more than 24 hours or leading to death with no apparent cause other24 hours or leading to death with no apparent cause other than that of vascular origin.”

If symptoms resolve within 24 hours the episode is called a transient ischemic attack – TIA*.

* Total risk 25% for stroke in 90 days

Page 12: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Types of stroke• thromboembolism • hemorrhage

Hemorrhagic stroke 15%

• thromboembolism • hemorrhage

stroke 15%• intracranial 67%

• SAH 33%

IschemicIschemic stroke

(infarction) 85%

Page 13: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Types of stroke vary in the world.y y

Page 14: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Determinants of strokeDeterminants of strokeNonmodifiable risk factors

♦ Age♦ Age♦ Gender♦ Ethnicity

Heredity♦ HeredityModifiable risk factors

♦ Hypertension♦ Hypertension♦ Diabetes♦ Cardiac disease (atrial fibrillation)

Hypercholesterolemia♦ Hypercholesterolemia♦ Cigarette smoking♦ Alcohol abuse♦ Physical inactivity

Page 15: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Cerebral infarctionCerebral infarction

Morphologic Evolution

Page 16: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Sequence of microscopic changes in brain infarctsq p g

> 1 hour Microvacuoles within neurons(swollen mitochondria)

P i l l tiPerineuronal vacuolation(swollen astrocytic processes)

Page 17: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Sequence of microscopic changes in brain infarctsq p g

> 1 hour Microvacuoles within neurons(swollen mitochondria)

P i l l tiPerineuronal vacuolation(swollen astrocytic processes)

4-12 hours Neuronal cytoplasmic eosinophiliay p pDisappearance of Nissl bodiesPyknotic nucleiLeakage of blood-brain barrier

Page 18: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Sequence of microscopic changes in brain infarctsq p g

> 1 hour Microvacuoles within neurons(swollen mitochondria)

P i l l tiPerineuronal vacuolation(swollen astrocytic processes)

4-12 hours Neuronal cytoplasmic eosinophiliay p pDisappearance of Nissl bodiesPyknotic nucleiLeakage of blood-brain barrier

15-24 hours Neutrophil infiltration begins

Page 19: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Sequence of microscopic changes in brain infarctsq p g

> 1 hour Microvacuoles within neurons(swollen mitochondria)

P i l l tiPerineuronal vacuolation(swollen astrocytic processes)

4-12 hours Neuronal cytoplasmic eosinophiliay p pDisappearance of Nissl bodiesPyknotic nucleiLeakage of blood-brain barrier

15-24 hours Neutrophil infiltration begins

2-3 days Macrophages (foam cells) appear5 days Neutrophilic infiltration ceases~ 1 week Proliferation of astrocytes around

core infarctcore infarct

Page 20: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Sequence of microscopic changes in brain infarctsq p g

> 1 hour Microvacuoles within neurons(swollen mitochondria)

P i l l tiPerineuronal vacuolation(swollen astrocytic processes)

4-12 hours Neuronal cytoplasmic eosinophiliay p pDisappearance of Nissl bodiesPyknotic nucleiLeakage of blood-brain barrier

15-24 hours Neutrophil infiltration begins

2-3 days Macrophages (foam cells) appear5 days Neutrophilic infiltration ceases~ 1 week Proliferation of astrocytes around

core infarctcore infarct

Page 21: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Topographic features – size & extent of infarct

Site of occlusion

Presence/absence

of anastomosisOphthalmic artery (EC-IC)p y ( )

The circle of Willis

Leptomeningial anastomosis

Page 22: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 23: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 24: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 25: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 26: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Underlying conditions of infarction

I Ath l iI. Atherosclerosis

Page 27: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 28: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 29: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 30: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 31: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 32: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Underlying conditions of infarction

II. Arteriolar sclerosis(small vessel disease)( )

• agingg g• sustained systemic hypertension• diabetes mellitus

Page 33: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 34: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 35: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 36: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 37: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Underlying conditions of infarctiony g

III. Cerebral embolism

Page 38: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Some causes of cerebral embolismLarge or small emboli:g

♦ atrial fibrillation♦ myocardial infarction♦ bacterial endocarditis♦ bacterial endocarditis♦ rheumatic endocarditis♦ nonbacterial endocarditis

di♦ cardiac surgery♦ arterial thrombosis

Small emboli:Small emboli:♦ ulcerated atheroma♦ trauma (fat emboli)

Page 39: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 40: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 41: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 42: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 43: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Underlying conditions of infarctiony g

IV. Vasculitis/vasculitides

Page 44: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Inflammatory CNS vascular diseasesN i f ti litidNon-infectious vasculitides

Primary cranial and/or cerebral inflammations♦ Takayasu’s arteritis♦ giant cell or temporal arteritis♦ primary angiitis of the CNS

(granulomatous angiitis)(granulomatous angiitis)Manifestations of systemic diseases

♦ systemic lupus erythematosuspolyarteritis nodosa♦ polyarteritis nodosa

♦ Wegener’s granulomatosis♦ Churg-Strauss syndrome♦ Behcet’s syndrome♦ malignancy related

Drug induced vasculitisDrug induced vasculitisInfectious vasculitis

Page 45: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Cerebral hemorrhageCerebral hemorrhage

• intracerebral • subarachnoid

• epidural /subdural (trauma)

Page 46: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

I. Intracerebral hemorrhageIncidence:Incidence:Asians > African Americans > Caucasians

Causes of non-traumatic ICH:Causes of non traumatic ICH:hypertension 50%cerebral amyloid angiopathy 12%anticoagulants 10%anticoagulants 10%tumors 8%illicit and licit drugs 6%arteriovenous malformations and aneurysms 5%miscellaneous 9%

Page 47: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Hypertensive hemorrhagehemorrhage

Frequent sitesFrequent sites of

involvement

Page 48: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 49: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 50: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 51: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 52: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 53: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Cerebral hemorrhage

II. SAH subarachnodial hemorrhage

Frequency: Approx. 5% of all strokesReported annual incidence: 10-11 / 100,000p

• Non-traumatic conditions♦ rupture of aneurysm* 80%♦ rupture of aneurysm 80%♦ arteriovenous malformations** 5-10%♦ unidentified cause 10-15%

• Traumatic

Page 54: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 55: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Underlying conditions of SAH

a. Saccular (berry) aneurysms

Frequency at autopsy: 1 to 6%Age at autopsy: 30 - 70 yrsSex ratio: F:M = 3:2Sex ratio: F:M = 3:2Associated hypertension: 50%Familial: RareLocation: Anterior circulation > 80%

Posterior circulation < 20%Multiple: 20%pRuptured aneurysms: Size > 0.5 cmMortality: 60%

Page 56: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 57: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 58: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 59: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 60: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Cerebral hemorrhage

2 A t i lf ti2. Arteriovenous malformation

IPH / SAHIPH / SAH

Page 61: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Arteriovenous malformationsClinical onset: Age 10 to 40Sex ratio: M:F = 2:1Location: Usually supratentorialy pClinical presentation: Headache, seizures,

focal neurologic deficit,hemorrhagehemorrhage

Angiography: Evidence of arteriovenous shunt and abnormal bl d lblood vessels

Mortality afterhemorrhage: 20%g

Page 62: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 63: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 64: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 65: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 66: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)
Page 67: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

Genetics and StrokeGenetic cardiovascular disorders leading to thromboemboli in CNSArterial dissection, Cardiomyopathies, Neuromuscular diseases, Metabolic conditions

(e.g. Homocysteinuria, Coagulopathies, Dyslipidaemia)

G ti t b li di d t b t t CNS l (Genetic metabolic disorders prone to obstruct CNS vessels (e.g. Fabry’s disease)

CADASIL (AD arteriopathy with subcortical infarcts and leukoencephalopathy)C S ( a te opat y w t subco t ca a cts a d eu oe cep a opat y)

notch 3

MELAS (Mitochondrial encephalomyopathy with lactic acidosis and stroke-like ( p y p yepisodes)

mitochondrial DNA mutations

Page 68: Cerebrovascular DiseaseCerebrovascular DiseaseFabry’s disease) CCSADASIL (AD aate opat yrteriopathy wwtith subcosubco t cartical infaactsa drcts and leueu oe cep a opat ykoencephalopathy)

The EndThe End

OENJOY small group study!